Zydus Lifesciences faces 108.54 million rupee stamp duty demand from Gujarat authority
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty 100 and 1.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Zydus Lifesciences received an order dated July 22, 2026 from the Superintendent of Stamps, Gandhinagar, regarding a Sale Deed for assets acquired from joint venture Sterling Biotech Limited. The authority valued the transferred property (land, buildings, plant and machinery) at about 1,542.60 million rupees and ordered recovery of 53.47 million rupees in deficient stamp duty plus penalties of 55.07 million rupees, totalling 108.54 million rupees. The company is evaluating legal remedies.
Modest financial impact at about 108.54 million rupees. Company is evaluating legal options, so final outcome remains uncertain.